As of 2025-04-28, the Fair Value of Pliant Therapeutics Inc (PLRX) is -17.17 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.46 USD, the upside of Pliant Therapeutics Inc is -1,276.06%.
With the market price of 1.46 USD and our fair value calculation, Pliant Therapeutics Inc (PLRX) is not a good investment. Investing in PLRX stocks now will result in a potential loss of 1,276.06%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -41.53 | -97.26 | -123.32 | -161.34 | -210.30 | -126.75 |
| YoY growth | -6,492.06% | -134.19% | -26.79% | -30.83% | -30.35% | -1,342.85% |
| Market Cap (mil) | 89.41 |
| P/E | |
| Forward P/E |
| EPS | -3.43 |
| Avg earnings growth rate | -1,342.85% |
| TTM earnings | -210.30 |